United Therapeutics Corp
F:UTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
United Therapeutics Corp
F:UTH
|
US |
|
Rekor Systems Inc
F:38E
|
US |
|
Sitowise Group Oyj
F:1FT
|
FI |
|
G
|
Grupa Azoty SA
WSE:ATT
|
PL |
|
L
|
LSB Industries Inc
XBER:LS3
|
US |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
DUS:AIL
|
FR |
|
Redcare Pharmacy NV
F:RDC
|
NL |
|
Loandepot Inc
F:LDD
|
US |
|
Grupa Azoty SA
F:5PL
|
PL |
|
K
|
Koninklijke Philips NV
XHAM:PHI1
|
NL |
|
Orchid Island Capital Inc
F:45U0
|
US |
|
Natwest Group PLC
F:RYS
|
UK |
|
K
|
Kikkoman Corp
XMUN:KIK
|
JP |
Wall St Price Targets
UTH Price Targets Summary
United Therapeutics Corp
According to Wall Street analysts, the average 1-year price target for UTH is 459.03 EUR with a low forecast of 351.09 EUR and a high forecast of 530.52 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UTH's stock price target?
Price Target
459.03
EUR
According to Wall Street analysts, the average 1-year price target for UTH is 459.03 EUR with a low forecast of 351.09 EUR and a high forecast of 530.52 EUR.
What is the Revenue forecast for United Therapeutics Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for United Therapeutics Corp?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 6 years is 15%.
What is the Operating Income forecast for United Therapeutics Corp?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 14%.
What is the Pre-Tax Income forecast for United Therapeutics Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 11%.
What is the Net Income forecast for United Therapeutics Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 11%.
